Biography and Research Information
OverviewAI-generated summary
Paras Malik's research focuses on clinical outcomes and disease mechanisms across a range of medical conditions. Malik has investigated the occurrence of scurvy in contemporary society and the potential for therapeutic agents to cause hemolytic anemia in malaria patients. Additionally, Malik has examined the outcomes for patients with concurrent Chronic Lymphocytic Leukemia (CLL) and Non-small cell lung carcinoma (NSCLC), presenting findings through publications and posters. The researcher has also explored cases of pleuroparenchymal fibroelastosis in patients with COVID-19 and analyzed sociodemographic trends in lung transplantation in the United States between 2001 and 2021. Malik's work includes collaborations with Sai Nikhila Ghanta.
Metrics
- h-index: 10
- Publications: 56
- Citations: 1,257
Selected Publications
-
Outcomes of patients with concurrent Chronic Lymphocytic leukemia (CLL) and Non-small cell lung carcinoma (NSCLC) (2025)
-
CLL-623: Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma (2025)
-
POSTER: CLL-623 Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma (2025)
-
Scurvy in the Modern World: Extinct or Not? (2022)
Collaboration Network
Top Collaborators
- Scurvy in the Modern World: Extinct or Not?
- POSTER: CLL-623 Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- CLL-623: Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- Outcomes of patients with concurrent Chronic Lymphocytic leukemia (CLL) and Non-small cell lung carcinoma (NSCLC)
- MALARIA VS A THERAPEUTIC AGENT: CAUSE OF HEMOLYTIC ANEMIA?
- LUNG TRANSPLANTATION IN THE UNITED STATES: COMPARISON OF SOCIODEMOGRAPHIC TRENDS BETWEEN 2001 AND 2021
- PLEUROPARENCHYMAL FIBROELASTOSIS UNCOVERED IN A PATIENT WITH COVID-19 PRESENTING WITH PNEUMOTHORAX
- POSTER: CLL-623 Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- CLL-623: Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- Outcomes of patients with concurrent Chronic Lymphocytic leukemia (CLL) and Non-small cell lung carcinoma (NSCLC)
- POSTER: CLL-623 Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- CLL-623: Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- Outcomes of patients with concurrent Chronic Lymphocytic leukemia (CLL) and Non-small cell lung carcinoma (NSCLC)
- POSTER: CLL-623 Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- CLL-623: Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- Outcomes of patients with concurrent Chronic Lymphocytic leukemia (CLL) and Non-small cell lung carcinoma (NSCLC)
- MALARIA VS A THERAPEUTIC AGENT: CAUSE OF HEMOLYTIC ANEMIA?
- PLEUROPARENCHYMAL FIBROELASTOSIS UNCOVERED IN A PATIENT WITH COVID-19 PRESENTING WITH PNEUMOTHORAX
- LUNG TRANSPLANTATION IN THE UNITED STATES: COMPARISON OF SOCIODEMOGRAPHIC TRENDS BETWEEN 2001 AND 2021
- PLEUROPARENCHYMAL FIBROELASTOSIS UNCOVERED IN A PATIENT WITH COVID-19 PRESENTING WITH PNEUMOTHORAX
- LUNG TRANSPLANTATION IN THE UNITED STATES: COMPARISON OF SOCIODEMOGRAPHIC TRENDS BETWEEN 2001 AND 2021
- PLEUROPARENCHYMAL FIBROELASTOSIS UNCOVERED IN A PATIENT WITH COVID-19 PRESENTING WITH PNEUMOTHORAX
- POSTER: CLL-623 Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- CLL-623: Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- Scurvy in the Modern World: Extinct or Not?
- Scurvy in the Modern World: Extinct or Not?
- Scurvy in the Modern World: Extinct or Not?
- Scurvy in the Modern World: Extinct or Not?
- LUNG TRANSPLANTATION IN THE UNITED STATES: COMPARISON OF SOCIODEMOGRAPHIC TRENDS BETWEEN 2001 AND 2021
- Outcomes of patients with concurrent Chronic Lymphocytic leukemia (CLL) and Non-small cell lung carcinoma (NSCLC)
Similar Researchers
Based on overlapping research topics